118 related articles for article (PubMed ID: 19672814)
1. Parathyroid hormone upregulates BMP-2 mRNA expression through mevalonate kinase and Rho kinase inhibition in osteoblastic MC3T3-E1 cells.
Takase H; Yano S; Yamaguchi T; Kanazawa I; Hayashi K; Yamamoto M; Yamauchi M; Sugimoto T
Horm Metab Res; 2009 Dec; 41(12):861-5. PubMed ID: 19672814
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the mevalonate pathway rescues the dexamethasone-induced suppression of the mineralization in osteoblasts via enhancing bone morphogenetic protein-2 signal.
Kanazawa I; Yamaguchi T; Yano S; Hayashi K; Yamauchi M; Sugimoto T
Horm Metab Res; 2009 Aug; 41(8):612-6. PubMed ID: 19384817
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
5. Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression.
Kanazawa I; Yamaguchi T; Yano S; Yamauchi M; Sugimoto T
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E139-46. PubMed ID: 19001547
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.
Datta NS; Pettway GJ; Chen C; Koh AJ; McCauley LK
J Bone Miner Res; 2007 Jul; 22(7):951-64. PubMed ID: 17501623
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein-2 counterregulates interleukin-18 mRNA and protein in MC3T3-E1 mouse osteoblastic cells.
Hori M; Sawai H; Tsuji Y; Okamura H; Koyama K
Connect Tissue Res; 2006; 47(3):124-32. PubMed ID: 16753805
[TBL] [Abstract][Full Text] [Related]
8. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts.
Ohnaka K; Shimoda S; Nawata H; Shimokawa H; Kaibuchi K; Iwamoto Y; Takayanagi R
Biochem Biophys Res Commun; 2001 Sep; 287(2):337-42. PubMed ID: 11554731
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of osteoblast Phex expression by PTH.
Alos N; Ecarot B
Bone; 2005 Oct; 37(4):589-98. PubMed ID: 16084134
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells.
Bunyaratavej P; Hullinger TG; Somerman MJ
Exp Cell Res; 2000 Nov; 260(2):324-33. PubMed ID: 11035927
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone induces expression of the inducible cAMP early repressor in osteoblastic MC3T3-E1 cells and mouse calvariae.
Tetradis S; Nervina JM; Nemoto K; Kream BE
J Bone Miner Res; 1998 Dec; 13(12):1846-51. PubMed ID: 9844102
[TBL] [Abstract][Full Text] [Related]
12. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
[TBL] [Abstract][Full Text] [Related]
13. Identification of a PTH regulated gene selectively induced in vivo during PTH-mediated bone formation.
Robinson JA; Susulic V; Liu YB; Taylor C; Hardenburg J; Gironda V; Zhao W; Kharode Y; McLarney S; Bai Y; Malone DP; Murrills R; Bex F
J Cell Biochem; 2006 Aug; 98(5):1203-20. PubMed ID: 16514668
[TBL] [Abstract][Full Text] [Related]
14. Cell-to-cell communication in osteoblastic networks: cell line-dependent hormonal regulation of gap junction function.
Donahue HJ; McLeod KJ; Rubin CT; Andersen J; Grine EA; Hertzberg EL; Brink PR
J Bone Miner Res; 1995 Jun; 10(6):881-9. PubMed ID: 7572312
[TBL] [Abstract][Full Text] [Related]
15. Effects of differentiation and transforming growth factor beta 1 on PTH/PTHrP receptor mRNA levels in MC3T3-E1 cells.
McCauley LK; Koh AJ; Beecher CA; Cui Y; Decker JD; Franceschi RT
J Bone Miner Res; 1995 Aug; 10(8):1243-55. PubMed ID: 8585429
[TBL] [Abstract][Full Text] [Related]
16. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2.
Lou J; Tu Y; Li S; Manske PR
Biochem Biophys Res Commun; 2000 Feb; 268(3):757-62. PubMed ID: 10679278
[TBL] [Abstract][Full Text] [Related]
17. Butyrate response factor 1 is regulated by parathyroid hormone and bone morphogenetic protein-2 in osteoblastic cells.
Reppe S; Olstad OK; Rian E; Gautvik VT; Gautvik KM; Jemtland R
Biochem Biophys Res Commun; 2004 Nov; 324(1):218-23. PubMed ID: 15465005
[TBL] [Abstract][Full Text] [Related]
18. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells.
Maeda T; Matsunuma A; Kurahashi I; Yanagawa T; Yoshida H; Horiuchi N
J Cell Biochem; 2004 Jun; 92(3):458-71. PubMed ID: 15156558
[TBL] [Abstract][Full Text] [Related]
19. Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression.
Kanazawa I; Yamaguchi T; Yano S; Yamauchi M; Sugimoto T
Biochem Biophys Res Commun; 2008 Oct; 375(3):414-9. PubMed ID: 18721796
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone induces receptor activity modifying protein-3 (RAMP3) expression primarily via 3',5'-cyclic adenosine monophosphate signaling in osteoblasts.
Phelps E; Bezouglaia O; Tetradis S; Nervina JM
Calcif Tissue Int; 2005 Aug; 77(2):96-103. PubMed ID: 16075364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
